High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD

Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation

(2011) B-M Svahn et al.   BONE MARROW TRANSPLANTATION

The Costs and Cost-Effectiveness of Allogeneic Peripheral Blood Stem Cell Transplantation versus Bone Marrow Transplantation in Pediatric Patients with Acute Leukemia

(2010) Yu-Feng Lin et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

(2010) Daniel Wolff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality

(2009) F L Dignan et al.   BONE MARROW TRANSPLANTATION

Costs of pediatric allogeneic hematopoietic-cell transplantation

(2009) Navneet S. Majhail et al.   PEDIATRIC BLOOD & CANCER

Evaluation of Readmission in Children Receiving Allogeneic Hematopoietic Stem Cell Transplantation: An Institutional Experience

(2008) T.-H. Jaing et al.   TRANSPLANTATION PROCEEDINGS